megestrol has been researched along with Albright Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brailly, S; Chanson, P; Couzinet, B; Kujas, M; Meduri, G; Schaison, G; Thomas, JL; Young, J | 1 |
| Raub, W | 1 |
2 other study(ies) available for megestrol and Albright Syndrome
| Article | Year |
|---|---|
The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
Topics: Adolescent; Adult; Amenorrhea; Estradiol; Female; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Luteinizing Hormone; Megestrol; Norpregnadienes; Ovary; Periodicity; Pituitary Gland; Progesterone; Progesterone Congeners; Receptors, Progesterone | 1999 |
From the National Institutes of Health.
Topics: Anorexia; Cachexia; Feeding and Eating Disorders; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; GTP-Binding Proteins; HIV Infections; Humans; Macrophages; Megestrol; National Institutes of Health (U.S.); Neoplasms; United States; Zidovudine | 1990 |